BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10065111)

  • 1. Allogeneic bone marrow transplantation for severe aplastic anemia: the Hong Kong scenario.
    Au WY; Lie AK; Kwong YL; Chan TK; Chim CS; Lee CK; Chiu EK; Liang R
    Hematol Oncol; 1998 Jun; 16(2):41-6. PubMed ID: 10065111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?
    Lawlor ER; Anderson RA; Davis JH; Fryer CJ; Pritchard SL; Rogers PC; Wu JK; Schultz KR
    J Pediatr Hematol Oncol; 1997; 19(2):115-23. PubMed ID: 9149740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation for fourteen patients with severe aplastic anemia.
    Hsueh EJ; Hwang WS; Huang SH; Chao TY; Chang JY; Wang CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):247-53. PubMed ID: 8705875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
    Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithymocyte immunoglobulin in severe aplastic anemia and bone marrow transplantation.
    Colby C; Stoukides CA; Spitzer TR
    Ann Pharmacother; 1996 Oct; 30(10):1164-74. PubMed ID: 8893124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
    Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
    Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy Consortium.
    Pulsipher MA; Lehmann LE; Bertuch AA; Sasa G; Olson T; Nakano T; Gilio A; Burroughs LM; Lipton JM; Huang JN; Dickerson K; Bertaina A; Zhuang C; Malsch M; Fleming M; Weller E; Shimamura A; Williams DA
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28444. PubMed ID: 32776425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation.
    Trede NS; Warwick AB; Rosoff PM; Rohrer R; Bierer BE; Guinan E
    Bone Marrow Transplant; 1997 Aug; 20(3):257-60. PubMed ID: 9257897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
    Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
    Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia.
    Kanda Y; Usuki K; Inagaki M; Ohta A; Ogasawara Y; Obara N; Kako S; Kurokawa M; Shimada N; Suzuki T; Hama A; Yamaguchi H; Nakao S; Yamazaki H
    Int J Hematol; 2023 May; 117(5):660-668. PubMed ID: 36595144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
    Doney K; Leisenring W; Storb R; Appelbaum FR
    Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
    Reiter E; Keil F; Brugger S; Kalhs P; Rabitsch W; Hinterberger W; Fischer G; Rosenmayr A; Haas O; Volc B; Lechner K; Greinix HT
    Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation in pediatric patients with severe aplastic anemia: cyclophosphamide and anti-thymocyte globulin conditioning followed by recombinant human granulocyte-macrophage colony stimulating factor.
    Bunin N; Leahey A; Kamani N; August C
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):68-71. PubMed ID: 8556374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
    Ellis RJ; Kahn Q; Skikne BS; Mayo MS; Allgood JW; Bodensteiner DM; Deauna-Limayo D; Cook JD
    Mil Med; 2002 Jul; 167(7):541-5. PubMed ID: 12125844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Second allogenic bone marrow transplantation after late graft rejection in a patient with severe aplastic anemia].
    Stamatović D; Balint B; Todorić-Zivanović B; Marjanović S; Lakić-Trajković Z; Malesević M
    Vojnosanit Pregl; 2000; 57(5):95-8. PubMed ID: 11213682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.